This case suggests a mechanistic rationale for the clinical efficacy of intravenous immunoglobulins (IVIG) in treating CD40 ligand (CD40L) deficiency associated neutropenia as it is the first reported instance of free and cell-bound antineutrophil antibodies in a case of CD40L deficiency, accompanied by a prolonged and clinically severe neutropenia.
Keywords: CD40 ligand deficiency; hyper‐IgM syndrome; neutropenia; neutrophil IgG auto‐antibodies.
© 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.